Smiths Medical 21-7232-24 - SET, INSULIN, CLEO, 9MM, 42", 28G, 25G CANN, 10 EA/BX
The Smiths Medical 21-7232-24 Cleo insulin infusion set is designed for reliable insulin delivery in patients using compatible insulin pump therapy systems. This infusion set includes a 9mm cannula, 42 inch tubing, 28G insertion needle, and 25G cannula configuration, offering a practical option for routine diabetes management where consistent subcutaneous insulin infusion is required.
Packaged as 10 each per box, this insulin infusion set supports clinical, home care, and diabetes management settings that require dependable infusion supplies. Its design helps support patient comfort, secure placement, and efficient connection during prescribed insulin therapy.
Key Benefits
The Smiths Medical 21-7232-24 Cleo insulin set provides a convenient all-in-one infusion solution for insulin pump users and healthcare providers. The 9mm cannula length supports subcutaneous delivery, while the 42 inch tubing offers flexibility for daily movement and pump positioning.
The 28G needle and 25G cannula combination is intended to support smooth insertion and reliable insulin flow. The boxed quantity of 10 each helps clinics, diabetes educators, and patients maintain an organized supply for scheduled infusion set changes.
This product is especially useful for users who need a consistent infusion set format, dependable tubing length, and a recognized medical-grade design for insulin pump therapy.
Compatibility and Applications
The Smiths Medical 21-7232-24 insulin infusion set is intended for use with compatible insulin pump therapy systems as directed by the device manufacturer, healthcare provider, or diabetes care team. It is commonly used in diabetes management programs that require continuous subcutaneous insulin infusion.
Typical applications include prescribed insulin pump therapy, routine infusion set replacement, outpatient diabetes care, endocrinology practice support, home healthcare supply management, and patient self-management under professional guidance.
Before use, compatibility should always be confirmed with the relevant insulin pump system and clinical instructions. Healthcare professionals should ensure that the tubing length, cannula size, and insertion depth are appropriate for the individual patients therapy plan.
Usage Guidelines
Use the Smiths Medical 21-7232-24 Cleo insulin infusion set only as directed by a qualified healthcare provider and in accordance with the instructions supplied with the product and compatible insulin pump system.
Inspect the package before use to confirm that it is unopened, undamaged, and within the applicable expiration period. Prepare the insertion site according to the patients diabetes care protocol and standard infection control procedures. Insert and connect the infusion set following the manufacturers instructions, ensuring that the tubing is properly primed and securely connected before therapy begins.
Infusion sites should be monitored regularly for redness, swelling, discomfort, leakage, poor adhesion, or signs of irritation. Replace the infusion set according to clinical guidance, manufacturer recommendations, and the patients prescribed pump therapy schedule.
Certifications and Safety Standards
The Smiths Medical 21-7232-24 Cleo insulin infusion set is manufactured for medical use and should be handled according to applicable healthcare standards for insulin delivery supplies. As with all infusion therapy products, safe use depends on proper storage, correct technique, compatible equipment, and adherence to clinical instructions.
Users should review the product packaging and manufacturer documentation for applicable regulatory markings, sterility status, storage requirements, lot information, expiration date, and safety instructions. Healthcare facilities should maintain proper documentation and follow internal purchasing, storage, and patient safety protocols.
Comparison with Competitors
Compared with general insulin infusion sets, the Smiths Medical 21-7232-24 Cleo set offers a defined configuration with 9mm cannula length, 42 inch tubing, 28G needle, and 25G cannula sizing. This makes it easier for healthcare teams and patients to match supply orders with an established insulin pump therapy routine.
Its 10 each box packaging supports predictable inventory management, especially for patients who regularly replace infusion sets and for clinics that assist multiple diabetes patients. The combination of tubing length, cannula depth, and needle size helps position this product as a practical choice where a consistent Cleo insulin infusion set format is required.
When selecting between infusion set options, users should compare compatibility, cannula length, tubing length, insertion method, patient comfort, clinical preference, and the recommendations of the prescribing healthcare professional.
Typical User Profile and Application Scenarios
The Smiths Medical 21-7232-24 insulin infusion set is suitable for patients using compatible insulin pump therapy under professional supervision. It may be used by adults or other appropriate patient groups when prescribed and confirmed by a healthcare provider.
Common users include diabetes patients managing insulin pump therapy at home, endocrinology clinics, diabetes educators, outpatient care providers, home healthcare teams, and medical supply departments supporting ongoing diabetes care.
Typical scenarios include routine infusion set replacement, transition to a compatible infusion set type, replenishment of insulin pump supplies, patient training sessions, and ongoing diabetes therapy management where a 9mm cannula and 42 inch tubing configuration is required.
Best Practices for Use and Maintenance
Store the Smiths Medical 21-7232-24 Cleo insulin infusion set in a clean, dry environment and protect it from extreme temperatures, moisture, and contamination. Keep the product in its original packaging until ready for use.
Rotate insertion sites as recommended by the healthcare provider to help reduce irritation and support consistent insulin absorption. Always wash hands before handling the infusion set, prepare the site carefully, and avoid touching sterile components that will enter or connect to the infusion pathway.
After placement, check the site and tubing regularly to ensure that the set remains secure and that insulin delivery is not interrupted. Dispose of used needles, cannulas, and related sharps or medical waste according to local regulations and the patients care instructions.
Regulatory and Safety Information
The Smiths Medical 21-7232-24 Cleo insulin infusion set should be used only for its intended purpose and only with compatible insulin pump systems. It is not a substitute for medical advice, blood glucose monitoring, prescribed insulin therapy, or professional diabetes management.
Patients should contact their healthcare provider if they experience unexplained high or low blood glucose readings, infusion site pain, leakage, irritation, infection symptoms, occlusion alerts, or suspected interruption of insulin delivery. Do not use the product if the packaging is damaged, opened, contaminated, or expired.
Follow all manufacturer instructions, prescribing information, facility policies, and local medical waste disposal requirements. Any serious product issue or suspected device-related problem should be reported through the appropriate clinical and regulatory channels.
How to Order
Select the Smiths Medical 21-7232-24 SET, INSULIN, CLEO, 9MM, 42", 28G, 25G CANN, 10 EA/BX and add it to your cart. Complete checkout with your preferred shipping and payment options. For bulk orders, quotes, or further assistance, contact CIA Medical customer service at (312)275-5850 or use the contact form on this page.
